Reduction in Insulin Dose Following Shift from Biphasic Human Insulin to Biphasic Insulin Aspart30/70: Experience from Indian-Cohort of IMPROVE™ Study

被引：0
|
作者：
Shah, Siddharth
Banerjee, Samar
Lamba, P. S.
Chakkarwar, Praful N.
Prusty, Vinay
Moharana, Ashok Kumar
Mazumdar, Anirban
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A534 / A535
页数：2
相关论文
共 50 条
  • [1] Switch from biphasic human insulin 30 to biphasic insulin aspart 30 in Pakistani subjects
    Hassan, Mohammad Imtiaz
    Aamir, Azizul Hasan
    Miyan, Zahid
    Siddiqui, Laiq Ahmed
    Mahmood, Shahid
    Vohra, Ejaz Ahmed
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (10) : 1290 - 1294
  • [2] A Comparison of Pharmacokinetics and Pharmacodynamics of Insulin Aspart, Biphasic Insulin Aspart 70, Biphasic Insulin Aspart 50, and Human Insulin: A Randomized, Quadruple Crossover Study
    Ma, Zhulin
    Parkner, Tina
    Frystyk, Jan
    Laursen, Torben
    Lauritzen, Torsten
    Christiansen, Jens Sandahl
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (07) : 589 - 595
  • [3] The pharmacokinetic and pharmacodynamic properties of biphasic insulin aspart 70 (BIAsp 70) are significantly different from those of biphasic insulin aspart 30 (BIAsp 30)
    Bott, S
    Tusek, C
    Heinemann, L
    Friberg, HH
    Heise, T
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (09) : 545 - 550
  • [4] Modeling of Pharmacokinetic Profiles of Insulin Aspart and Biphasic Insulin Aspart 30/70
    Kulesh, Victoria S.
    Drai, Roman, V
    Zinnatulina, Bella R.
    Makarenko, Igor E.
    Pilyus, Fedor G.
    Khokhlov, Alexander L.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (09): : 1086 - 1093
  • [5] Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study
    Yang, Wenying
    Gao, Yan
    Liu, Guoliang
    Chen, Lulu
    Fu, Zuzhi
    Zou, Dajin
    Feng, Ping
    Zhao, Zhigang
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (01) : 101 - 107
  • [6] LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS
    Ligthelm, R.
    Christensen, T. E.
    Thomsen, T. L.
    Yang, W.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A402 - A402
  • [7] Clinical Effectiveness of Biphasic Insulin Aspart 30:70 Versus Biphasic Human Insulin 30 in UK General Clinical Practice: A Retrospective Database Study
    Morgan, Christopher Li
    Evans, Marc
    Toft, Anders D.
    Jenkins-Jones, Sara
    Poole, Chris D.
    Currie, Craig J.
    [J]. CLINICAL THERAPEUTICS, 2011, 33 (01) : 27 - 35
  • [8] Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70
    Ohira, Masahiro
    Endo, Kei
    Oyama, Tomokazu
    Yamaguchi, Takashi
    Ban, Noriko
    Kawana, Hidetoshi
    Nagayama, Daiji
    Nagumo, Ayako
    Saiki, Atsuhito
    Murano, Takeyoshi
    Watanabe, Hitoshi
    Miyashita, Yoh
    Shirai, Kohji
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (01): : 78 - 85
  • [9] Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study
    Shestakova, M.
    Sharma, S. K.
    Almustafa, M.
    Min, K. W.
    Ayad, N.
    Azar, S. T.
    Danciulescu, R.
    Khutsoane, D.
    Guler, S.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 3209 - 3214
  • [10] Improvement in Metabolic Control in Type 2 Diabetic Patients after Switching from Biphasic Human Insulin to Biphasic Insulin Aspart 30/70: An Observational Study in Hungary
    Geroe, Laszlo
    Gyimesi, Andras
    Hidvegi, Tibor
    [J]. DIABETES, 2009, 58 : A527 - A527
12345